Literature DB >> 208971

Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activation.

S M Silver, A Scheid, P W Choppin.   

Abstract

Primary and secondary cultures of rhesus monkey kidney cells supported multiple-cycle replication of Sendai virus, but later passages lost this ability, and this was reflected in decreased plaque formation. Multiple-cycle replication also did not occur in LLC-MK2 cells, a continuous line of RMK cells. Failure of replication in serially passed cells was correlated with a decrease in proteolytic cleavage of a viral surface glycoprotein (Fo), and the ability of cells to support multiple-cycle replication and plaque formation could be restored by the addition of trypsin (0.3 microgram/ml) to the overlay medium. The use of wild-type virus, which requires trypsin, and protease activation mutants that require chymotrypsin or elastase for activation has provided evidence that the activating protease supplied by primary or secondary cells has trypsin-like activity. Inactive virus, with uncleaved Fo glycoprotein, absorbed to primary or secondary cells but did not infect them, even though such cells possess the enzyme that is capable of cleaving the Fo glycoprotein of virus synthesized in these cells. The inability of these cells to activate adsorbed virus indicates that the activating protease that they possess is inacessible to adsorbed virus, although it can act on the Fo glycoprotein during virus maturation in these cells. These data provide a biochemical explanation for the failure of later passages of a cell strain or a continuous cell line to support the replication of a paramyxovirus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208971      PMCID: PMC421577          DOI: 10.1128/iai.20.1.235-241.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Cytochemistry and sensitivity of a human amnion cell-line to Coxsackie A23 (ECHO9) virus.

Authors:  H BEEUWKES
Journal:  Antonie Van Leeuwenhoek       Date:  1960       Impact factor: 2.271

2.  STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. I. THE RELATION BETWEEN POLIOVIRUS,-INDUCED METABOLIC AND MORPHOLOGICAL ALTERATIONS IN CULTURED CELLS.

Authors:  R BABLANIAN; H J EGGERS; I TAMM
Journal:  Virology       Date:  1965-05       Impact factor: 3.616

3.  Plaque formation by influenza A2 virus in monkey kidney cells.

Authors:  P W CHOPPIN
Journal:  Virology       Date:  1962-10       Impact factor: 3.616

4.  Studies on tissue cultures of human pathological thyroids.

Authors:  R J PULVERTAFT; J R DAVIES; L WEISS; J H WILKINSON
Journal:  J Pathol Bacteriol       Date:  1959-01

5.  Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

6.  Polypeptide synthesis in simian virus 5-infected cells.

Authors:  R W Peluso; R A Lamb; P W Choppin
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

7.  Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells.

Authors:  M Homma; M Ouchi
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

8.  Plaque formation by sendai virus of parainfluenza virus group, type 1 on monkey, calf kidney and chick embryo cell monolayers.

Authors:  H Shibuta; M Akami; M Matumoto
Journal:  Jpn J Microbiol       Date:  1971-03

9.  Sendai virus replication: an ultrastructural comparison of productive and abortive infections in avian cells.

Authors:  R W Darlington; A Portner; D W Kingsbury
Journal:  J Gen Virol       Date:  1970-12       Impact factor: 3.891

10.  The inactivation of enterovirus infectivity by the sulfhydryl reagent p-chloromercuribenzoate.

Authors:  P W CHOPPIN; L PHILIPSON
Journal:  J Exp Med       Date:  1961-04-01       Impact factor: 14.307

View more
  14 in total

1.  Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.

Authors:  M Itoh; T D Ming; T Hayashi; Y Mochizuki; M Homma
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.

Authors:  X L Wang; M Itoh; H Hotta; M Homma
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

3.  Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity.

Authors:  H Shibuta; T Kanda; A Hazama; A Adachi; M Matumoto
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

4.  Membrane proteins and virus virulence.

Authors:  P W Choppin
Journal:  Trans Am Clin Climatol Assoc       Date:  1984

5.  Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2.

Authors:  M Tashiro; M Homma
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

6.  Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium.

Authors:  M Tashiro; M Yamakawa; K Tobita; H D Klenk; R Rott; J T Seto
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

7.  Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.

Authors:  M Tashiro; M Homma
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.

Authors:  M Tashiro; Y Yokogoshi; K Tobita; J T Seto; R Rott; H Kido
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin.

Authors:  Y Mochizuki; M Tashiro; M Homma
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus.

Authors:  M Tashiro; Y Fujii; K Nakamura; M Homma
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.